Skip to main content

Advertisement

Log in

Comments on: The clinical relevance of various methods of classifying ipsilateral breast tumor recurrence as either true local recurrence or new primary

  • Letter to the Editor
  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Jobsen JJ, Struikmans H, Siemerink E, van der Palen J, Heijmans HJ (2022) The clinical relevance of various methods of classifying ipsilateral breast tumour recurrence as either true local recurrence or new primary. Breast Cancer Res Treat 195(3):249–262. https://doi.org/10.1007/s10549-022-06680-7

    Article  Google Scholar 

  2. Yi M, Buchholz TA, Meric-Bernstam F, Bedrosian I, Hwang RF, Ross MI et al (2011) Classification of ipsilateral breast tumor recurrences after breast conservation therapy can predict patient prognosis and facilitate treatment planning. Ann Surg 253(3):572–579. https://doi.org/10.1097/SLA.0b013e318208fc2a

    Article  Google Scholar 

  3. Nakagomi H, Inoue M, Hirotsu Y, Amemiya K, Mochiduki H, Omata M (2022) PIK3CA-AKT pathway predominantly acts in developing ipsilateral breast tumor recurrence long after breast-conserving surgery. Breast Cancer Res Treat. https://doi.org/10.1007/s10549-022-06570-y

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhi-Ming Shao.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Qu, FL., Li, JJ. & Shao, ZM. Comments on: The clinical relevance of various methods of classifying ipsilateral breast tumor recurrence as either true local recurrence or new primary. Breast Cancer Res Treat 197, 243–244 (2023). https://doi.org/10.1007/s10549-022-06784-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10549-022-06784-0

Navigation